Niger vs Syria: Hepatitis B surface antigen (HBsAg) prevalence
Niger
3.2%
in 2024
Syria
2.9%
in 2024
Niger rank
3rd
Syria rank
6th
Hepatitis B surface antigen (HBsAg) prevalence over time
- Niger
- Syria
How they compare
Niger currently reports 3.2% against 2.9% in Syria, a difference of 0.3%.
That makes Niger's figure about 1.1 times Syria's.
The two have swapped places 1 time across 10 shared years of data; in 2015 it was Syria ahead.
Niger ranks 3rd and Syria ranks 6th of 194 countries.
Across the 2 decades both report, Niger averaged higher in 1 and Syria in 1.
Head to head by decade
| Decade | Niger | Syria | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2.6% | 3.5% | 0.8% | Syria |
| 2020s | 3.4% | 3.4% | 0.1% | Niger |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Niger or Syria?
- Niger, at 3.2% against 2.9% in Syria as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Niger and Syria?
- 0.3%, with Niger ahead.
- How many years of comparable data are there for Niger and Syria?
- 10 years are reported by both, from 2015 to 2024.
- How do Niger and Syria rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Niger ranks 3rd and Syria ranks 6th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.